Company intelligence / Profile preview

Pathline

Ramsey, New Jersey, United States

Ownership: Private
Development stage: Other

Overview

Pathline delivered rapid, high-volume cancer and COVID-19 diagnostic testing with fast turnaround times and CLIA/CAP/NYS credentials; post-acquisition, its services and team were fully integrated into NeoGenomics, expanding access to advanced molecular diagnostics in the Northeast USA

Therapeutic areas: OncologyInfectious DiseasesOther
Modalities: Molecular pathologyFlow cytometryFluorescence in situ hybridization (FISH)CytogeneticsImmunohistochemistryHistopathologyNext Generation Sequencing
Industry: Molecular Diagnostics

Partnerships

Leica Biosystems (workflow automation, sample tracking)

Beyond the preview

Go deeper on Pathline.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathline.

Explore the full profile